基于网络药理学和分子对接探讨银花泌炎灵片抗急性肾盂肾炎的作用机制^*

Exploring the mechanism of action of Yinhua Miyanling Tablets against acute pyelonephritis based on network pharmacology and molecular docking

摘要

目的 分析鉴定银花泌炎灵片的化学成分及其治疗急性肾盂肾炎的机制。方法 通过液相色谱-质谱 (LC-MS) 联用技术对银花泌炎灵片的化学成分进行分析和鉴定, 通过网络药理学和分子对接技术探讨其可能的作用机制。结果 LC-MS 技术新鉴定出银花泌炎灵片中 101 个化学成分。网络药理学分析得到核心靶点 126 个; 拓扑学分析筛选出肿瘤坏死因子等 10 个关键靶点, 葛根素等 28 个活性成分; 通路富集分析筛选出晚期糖基化终末产物-晚期糖基化终末产物受体等关键信号通路; 分子对接结果表明, 关键成分和关键靶点的结合能均小于-5 kJ/mol, 可形成稳定的氢键。结论 银花泌炎灵片含多种结构类型化学成分, 可通过 “多靶点-多通路” 发挥抗急性肾盂肾炎作用。

Abstract

Objective To analyse and identify the chemical components of Yinhua Miyanling Tablets, and to explore the mechanism treating acute pyelonephritis. Methods To conduct analysis and identification of the chemical components in Yinhua Miyanling Tablets by integration of liquid chromatography-mass spectrometry (LC-MS), and to explore the possible mechanisms of action by network pharmacology and molecular docking technology. Results A total of 101 chemical components were newly identified in Yinhua Miyanling Tablets by LC-MS. A total of 126 core targets were screened out based on network pharmacology. Based on network pharmacological strategy, a total of 10 key targets such as tumor necrosis factor, 28 key active chemical components such as Puerarin and key pathways such as advanced glycation end products-receptor for advanced glycation end products (AGE-RAGE) were screened out for the hypolipidemic effect of Yinhua Miyanling Tablets. The molecular docking results show that the binding energies between key components and the key targets were all less than -5 kJ/mol, and stable hydrogen bonds can be formed. Conclusion Yinhua Miyanling Tablets contain a variety of structural types of chemical components that could exert an anti-acute pyelonephritis effect through “multi targets-multi pathways”.

关键词

银花泌炎灵片 / 急性肾盂肾炎 / 化学成分 / 网络药理学 / 分子对接

Key words

Yinhua Miyanling Tablets / Acute pyelonephritis / Chemical components / Network pharmacology / Molecular docking

参考文献

[1] 李倩, 张庆娟, 朱江, 等 . 459 例急性肾盂肾炎致病菌的流行病学与细菌谱分析[J]. 国际移植与血液净化杂志, 2018, 16(6): 29-32.

[2] Li Q, Zhang Q J, Zhu J, et al. Epidemiology and bacterial spectrum analysis of 459 cases of acute pyelonephritis[J]. Int J Transplant Hemopurif, 2018, 16(6): 29-32.

[3] Lagu T, Rothberg M B, Shieh M S, et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007[J]. Crit Care Med, 2012, 40(3): 754-761.

[4] 曹雯, 廖祖春, 宋斌, 等 . 老年急性肾盂肾炎患者感染危险因素及病原菌耐药情况分析[J]. 国际检验医学杂志, 2021, 42(6): 690-694.

[5] Cao W, Liao Z C, Song B, et al. Risk factors of infection and drug resistance analysis of acute pyelonephritis in elderly patients[J]. Int J Lab Med, 2021, 42(6): 690-694.

[6] 于建忠, 吴阳阳, 孟玲玲 . 清利通淋汤加减治疗湿热型急性肾盂肾炎的临床观察[J]. 中国中医急症, 2022, 31(7): 1209-1211.

[7] Yu J Z, Wu Y Y, Meng L L. Clinical observation on the treatment of damp—heat type acute pyelonephritis by addition and subtraction of Qingli Tongyin Tang[J]. J Emerg Tradit Chin Med, 2022, 31(7): 1209-1211.

[8] 张文婷, 苗润培, 赵启菡, 等 . 银花泌炎灵片治疗尿路感染临床与基础研究[J]. 中国中药杂志, 2019, 44(11): 2403-2410.

[9] Zhang W T, Miao R P, Zhao Q H, et al. Clinical and fundamental research Yinhua Miyanling Tablets in treating urinary tract infection[J]. Chin J Chin Mater Med, 2019, 44(11): 2403-2410.

[10] 韩柳, 王翠竹, 董庆海, 等 . 基于 UPLC—Q—TOF/MSE 技术的银花泌炎灵片提取液全成分分析[J]. 吉林医药学院学报, 2022, 43(2): 81-84.

[11] Han L, Wang C Z, Dong Q H, et al. Analysis of total components of Yinhua Miyanling Tablets based on UPLC—Q—TOF/MS[J]. J Jilin Med Univ, 2022, 43(2): 81-84.

[12] 张庆贺, 刘海宇, 林美妤, 等 . 银花泌炎灵片挥发油化学成分的 GC—MS 分析[J]. 中国实验方剂学杂志, 2012, 18(15): 99-101.

[13] Zhang Q H, Liu H Y, Lin M Y, et al. GC—MS analysis of volatile oil constituents of Yinhua Miyanling Tablet[J]. Chin J Exp Tradit Med Form, 2012, 18(15): 99-101.

[14] 刘云鹤 . 美花风毛菊化学成分、抗溃疡性结肠炎作用及药代动力学研究[D]. 长春: 吉林大学, 2023.

[15] Liu Y H. Chemical composition, antiulcerative colitis effect and pharmacokinetics of Meihua pachyderm[D]. Changchun: Jilin University, 2023.

[16] Zhao J D, Wang J T, Liu J X, et al. Effect and mechanisms of kaempferol against endometriosis based on network pharmacology and in vitro experiments[J]. BMC Complement Med Ther, 2022, 22(1): 254.

[17] Eberhardt J, Santos—martins D, Tillack A, et al. AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings[J]. J Chem Inf Model, 2021, 61(8): 3891-3898.

[18] 陈安琴, 蒋伟芳 . 三金片联合左氧氟沙星治疗急性肾盂肾炎的临床疗效观察[J]. 中华中医药杂志, 2020, 35(4): 1900-1902.

[19] Chen A Q, Jiang W F. Clinical efficacy observation of Sanjin Tablets combined with levofloxacin in the treatment of acute pyelonephritis[J]. Chin J Tradit Chin Med Pharm, 2020, 35(4): 1900-1902.

[20] 李秋明, 张亚杰 . 健脾止泻颗粒对脾虚证及抗生素肠道菌群失调模型小鼠的微生态调节作用[J]. 中国中医基础医学杂志, 2010, 16(12): 1119-1120.

[21] Li Q M, Zhang Y J. Effects of Jianpi Zhixie Granules on intestinal microecology in rats with spleen deficiency syndrome and alteration of intestinal flora induced by antibiotics[J]. J Basic Chin Med, 2010, 16(12): 1119-1120.

[22] 赵璐, 张明泉, 徐耿瑞 . 基于网络药理学和分子对接技术研究寒痉汤治疗高血压病的作用机制[J]. 中医临床研究, 2022, 14(27): 1-10.

[23] Zhao L, Zhang M Q, Xu G R. Prediction of the potential mechanism of Hanjing decoction in treatment of hypertension based on network pharmacology and molecular docking[J]. Clin J Chin Med, 2022, 14(27): 1-10.

[24] Pevzner I B, Zorova L D, Galkin F A, et al. Mitochondria—associated matrix metalloproteinases 2 and 9 in acute renal pathologies[J]. Bull Exp Biol Med, 2019, 166(3): 334-338.

[25] 姚静, 杨彦坤, 杨柳, 等 . 急性肾盂肾炎发病机制的研究进展[J]. 医学综述, 2017, 23(6): 1071-1075.

[26] Yao J, Yang Y K, Yang L, et al. Research advances in pathogenesis of acute pyelonephritis[J]. Med Recapitulate, 2017, 23(6): 1071-1075.

[27] 花卉, 刘聪, 何宇霞, 等 . 基于网络药理学探究血尿胶囊治疗急性肾盂肾炎的作用机制[J]. 中国实验方剂学杂志, 2022, 28(2): 208-221.

[28] Hua H, Liu C, He Y X, et al. Mechanism of Xueniao Capsule in treatment of acute pyelonephritis based on network pharmacology[J]. Chin J Exp Tradit Med Form, 2022, 28(2): 208-221.

基金资助

^*吉林省中成药二次开发科技创新中心(YDZJ202402035CXJD)

吉林省中成药二次开发科技创新中心(20210502005ZP)

吉林省科技发展计划项目重大科技专项(20240208009JH)